The NHS, the drug firms and the price racket
Holly Watt, Claire Newell and Ben BryantPharmaceutical firms appear to have rigged the market in so-called "specials" – prescription drugs that are largely not covered by national NHS price regulations.
The prices of more than 20,000 drugs could have been artificially inflated, with backhanders paid to chemists who agreed to sell them.
Representatives of some companies agreed to invoice chemists for drugs at up to double their actual cost. Chemists would then send inflated invoices to the NHS, allowing them to pocket the difference.
Pour citer cette ressource :
"The NHS, the drug firms and the price racket", La Clé des Langues [en ligne], Lyon, ENS de LYON/DGESCO (ISSN 2107-7029), juin 2013. Consulté le 03/12/2023. URL: https://cle.ens-lyon.fr/anglais/archives/archives-revue-de-presse/the-nhs-the-drug-firms-and-the-price-racket